TECTONIC THERAPEUTIC, INC. Investment Income, Interest
TECTONIC THERAPEUTIC, INC. (TECX) reported Investment Income, Interest of $2.02 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. investment income, interest for the quarter ending 2026-06-30 was $2.02M, a 40.37% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. investment income, interest for the quarter ending 2026-03-31 was $2.18M, a 10.76% decline year-over-year.
- TECTONIC THERAPEUTIC, INC. investment income, interest for the quarter ending 2025-12-31 was $2.56M, a 47.78% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. investment income, interest for the quarter ending 2025-09-30 was $2.90M, a 48.57% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. investment income, interest for fiscal 2025 was $11.30M, a 165.13% increase from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. investment income, interest for fiscal 2024 was $4.26M, a 633.39% increase from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. investment income, interest for fiscal 2023 was $581.00K.
- TECTONIC THERAPEUTIC, INC. investment income, interest for fiscal 2020 was $719.00K, a 75.49% decline from fiscal 2019.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.02M 10-Q · filed 2026-08-06 | $4.20M 10-Q · filed 2026-08-06 | $6.77M derived: sum of 3 quarters · filed 2026-08-06 | $9.67M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $2.18M 10-Q · filed 2026-05-07 | $4.75M derived: sum of 2 quarters · filed 2026-05-07 | $7.64M derived: sum of 3 quarters · filed 2026-05-07 | $11.03M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $5.46M derived: sum of 2 quarters · filed 2026-02-26 | $8.85M derived: sum of 3 quarters · filed 2026-08-06 | $11.30M 10-K · filed 2026-02-26 |
| 2025-09-30 | $2.90M 10-Q · filed 2025-11-06 | $6.29M derived: sum of 2 quarters · filed 2026-08-06 | $8.73M 10-Q · filed 2025-11-06 | $10.47M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $3.39M 10-Q · filed 2026-08-06 | $5.83M 10-Q · filed 2026-08-06 | $7.57M derived: sum of 3 quarters · filed 2026-08-06 | $9.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.44M 10-Q · filed 2026-05-07 | $4.18M derived: sum of 2 quarters · filed 2026-05-07 | $6.13M derived: sum of 3 quarters · filed 2026-05-07 | $6.45M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.69M derived: sum of 2 quarters · filed 2026-02-26 | $4.00M derived: sum of 3 quarters · filed 2026-02-26 | $4.26M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.95M 10-Q · filed 2025-11-06 | $2.27M derived: sum of 2 quarters · filed 2025-11-06 | $2.53M 10-Q · filed 2025-11-06 | $2.66M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $318.00K 10-Q · filed 2025-08-07 | $574.00K 10-Q · filed 2025-08-07 | $707.00K derived: sum of 3 quarters · filed 2025-08-07 | $804.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $256.00K 10-Q · filed 2025-05-08 | $389.00K derived: sum of 2 quarters · filed 2025-05-08 | $486.00K derived: sum of 3 quarters · filed 2025-05-08 | $710.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $133.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $230.00K derived: sum of 2 quarters · filed 2025-03-20 | $454.00K derived: sum of 3 quarters · filed 2025-03-20 | $581.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $97.00K 10-Q · filed 2024-11-12 | $321.00K derived: sum of 2 quarters · filed 2024-11-12 | $448.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $224.00K 10-Q · filed 2024-08-14 | $352.00K 10-Q · filed 2024-08-14 | ||
| 2021-09-30 | $2.00K 10-Q · filed 2021-11-04 | $11.00K derived: sum of 2 quarters · filed 2021-11-04 | $21.00K 10-Q · filed 2021-11-04 | $34.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | $9.00K 10-Q · filed 2021-08-05 | $19.00K 10-Q · filed 2021-08-05 | $32.00K derived: sum of 3 quarters · filed 2021-08-05 | $44.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-03-31 | $10.00K 10-Q · filed 2021-05-13 | $23.00K derived: sum of 2 quarters · filed 2021-05-13 | $35.00K derived: sum of 3 quarters · filed 2021-11-04 | $97.00K derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $25.00K derived: sum of 2 quarters · filed 2021-11-04 | $87.00K derived: sum of 3 quarters · filed 2021-11-04 | $719.00K 10-K · filed 2021-03-18 |
| 2020-09-30 | $12.00K 10-Q · filed 2021-11-04 | $74.00K derived: sum of 2 quarters · filed 2021-11-04 | $706.00K 10-Q · filed 2021-11-04 | $1.49M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $62.00K 10-Q · filed 2021-08-05 | $694.00K 10-Q · filed 2021-08-05 | $1.48M derived: sum of 3 quarters · filed 2021-08-05 | $2.41M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $632.00K 10-Q · filed 2021-05-13 | $1.42M derived: sum of 2 quarters · filed 2021-05-13 | $2.35M derived: sum of 3 quarters · filed 2021-05-13 | $2.91M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $788.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $1.71M derived: sum of 2 quarters · filed 2021-03-18 | $2.28M derived: sum of 3 quarters · filed 2021-03-18 | $2.93M 10-K · filed 2021-03-18 |
| 2019-09-30 | $925.00K 10-Q · filed 2020-11-05 | $1.49M derived: sum of 2 quarters · filed 2020-11-05 | $2.15M 10-Q · filed 2020-11-05 | $2.83M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $565.00K 10-Q · filed 2020-08-06 | $1.22M 10-Q · filed 2020-08-06 | $1.91M derived: sum of 3 quarters · filed 2020-08-06 | $2.56M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $657.00K 10-Q · filed 2020-05-07 | $1.34M derived: sum of 2 quarters · filed 2020-05-07 | $1.99M derived: sum of 3 quarters · filed 2020-05-07 | $2.23M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $688.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $1.33M derived: sum of 2 quarters · filed 2020-03-16 | $1.57M derived: sum of 3 quarters · filed 2020-03-16 | $1.73M 10-K · filed 2020-03-16 |
| 2018-09-30 | $646.00K 10-Q · filed 2019-11-07 | $880.00K derived: sum of 2 quarters · filed 2019-08-08 | $1.04M 10-Q · filed 2019-11-07 | $1.07M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-06-30 | $234.00K 10-Q · filed 2019-08-08 | $392.00K 10-Q · filed 2019-08-08 | $427.00K derived: sum of 3 quarters · filed 2019-08-08 | $434.00K derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $158.00K 10-Q · filed 2019-05-13 | $193.00K derived: sum of 2 quarters · filed 2019-05-13 | $200.00K derived: sum of 3 quarters · filed 2019-05-13 | $211.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $42.00K derived: sum of 2 quarters · filed 2019-03-25 | $53.00K derived: sum of 3 quarters · filed 2019-03-25 | $57.00K 10-K · filed 2019-03-25 |
| 2017-09-30 | $7.00K 10-Q · filed 2018-11-13 | $18.00K derived: sum of 2 quarters · filed 2018-11-13 | $22.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $11.00K 10-Q · filed 2018-08-09 | $15.00K 10-Q · filed 2018-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |